Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1960 1
1961 1
1962 8
1963 18
1964 7
1965 8
1966 12
1967 19
1968 12
1969 5
1970 7
1971 4
1972 18
1973 9
1974 8
1975 9
1976 15
1977 15
1978 17
1979 20
1980 18
1981 17
1982 18
1983 16
1984 31
1985 29
1986 28
1987 35
1988 22
1989 37
1990 38
1991 35
1992 40
1993 64
1994 42
1995 41
1996 58
1997 49
1998 72
1999 86
2000 68
2001 81
2002 87
2003 93
2004 88
2005 114
2006 112
2007 133
2008 131
2009 138
2010 135
2011 154
2012 136
2013 117
2014 117
2015 115
2016 140
2017 168
2018 134
2019 133
2020 134
Text availability
Article attribute
Article type
Publication date

Search Results

3,249 results
Results by year
Filters applied: . Clear all
Page 1
Acute exacerbations of fibrotic interstitial lung diseases.
Suzuki A, Kondoh Y, Brown KK, Johkoh T, Kataoka K, Fukuoka J, Kimura T, Matsuda T, Yokoyama T, Fukihara J, Ando M, Tanaka T, Hashimoto N, Sakamoto K, Hasegawa Y. Suzuki A, et al. Among authors: yokoyama t. Respirology. 2020 May;25(5):525-534. doi: 10.1111/resp.13682. Epub 2019 Aug 19. Respirology. 2020. PMID: 31426125 Free article.
Rational Engineering of XCaMPs, a Multicolor GECI Suite for In Vivo Imaging of Complex Brain Circuit Dynamics.
Inoue M, Takeuchi A, Manita S, Horigane SI, Sakamoto M, Kawakami R, Yamaguchi K, Otomo K, Yokoyama H, Kim R, Yokoyama T, Takemoto-Kimura S, Abe M, Okamura M, Kondo Y, Quirin S, Ramakrishnan C, Imamura T, Sakimura K, Nemoto T, Kano M, Fujii H, Deisseroth K, Kitamura K, Bito H. Inoue M, et al. Among authors: yokoyama t. Cell. 2019 May 16;177(5):1346-1360.e24. doi: 10.1016/j.cell.2019.04.007. Epub 2019 May 9. Cell. 2019. PMID: 31080068 Free article.
Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
Yokoyama T, Takehara K, Sugimoto N, Kaneko K, Fujimoto E, Okazawa-Sakai M, Okame S, Shiroyama Y, Yokoyama T, Teramoto N, Ohsumi S, Saito S, Imai K, Sugano K. Yokoyama T, et al. BMC Cancer. 2018 May 21;18(1):576. doi: 10.1186/s12885-018-4489-0. BMC Cancer. 2018. PMID: 29783979 Free PMC article. Review.
Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc.
Lee Y, Wiriyasermkul P, Jin C, Quan L, Ohgaki R, Okuda S, Kusakizako T, Nishizawa T, Oda K, Ishitani R, Yokoyama T, Nakane T, Shirouzu M, Endou H, Nagamori S, Kanai Y, Nureki O. Lee Y, et al. Among authors: yokoyama t. Nat Struct Mol Biol. 2019 Jun;26(6):510-517. doi: 10.1038/s41594-019-0237-7. Epub 2019 Jun 3. Nat Struct Mol Biol. 2019. PMID: 31160781
Crown Ethers as Transthyretin Amyloidogenesis Inhibitors.
Yokoyama T, Mizuguchi M. Yokoyama T, et al. J Med Chem. 2019 Feb 28;62(4):2076-2082. doi: 10.1021/acs.jmedchem.8b01700. Epub 2019 Feb 8. J Med Chem. 2019. PMID: 30688456
Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
Katakami N, Uchino J, Yokoyama T, Naito T, Kondo M, Yamada K, Kitajima H, Yoshimori K, Sato K, Saito H, Aoe K, Tsuji T, Takiguchi Y, Takayama K, Komura N, Takiguchi T, Eguchi K. Katakami N, et al. Among authors: yokoyama t. Cancer. 2018 Feb 1;124(3):606-616. doi: 10.1002/cncr.31128. Epub 2017 Dec 4. Cancer. 2018. PMID: 29205286 Free PMC article. Clinical Trial.
Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non-small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study.
Kawachi H, Tamiya M, Tamiya A, Ishii S, Hirano K, Matsumoto H, Fukuda Y, Yokoyama T, Kominami R, Fujimoto D, Hosoya K, Suzuki H, Hirashima T, Kanazu M, Sawa N, Uchida J, Morita M, Makio T, Hara S, Kumagai T. Kawachi H, et al. Among authors: yokoyama t. Invest New Drugs. 2020 Feb;38(1):211-218. doi: 10.1007/s10637-019-00882-5. Epub 2019 Nov 30. Invest New Drugs. 2020. PMID: 31784866
Uterine leiomyosarcoma well-controlled with eribulin mesylate.
Fujimoto E, Takehara K, Tanaka T, Yokoyama T, Tomono K, Okazawa-Sakai M, Okame S, Sugawara Y, Teramoto N. Fujimoto E, et al. Among authors: yokoyama t. Int Cancer Conf J. 2018 Nov 12;8(1):33-38. doi: 10.1007/s13691-018-0350-1. eCollection 2019 Jan. Int Cancer Conf J. 2018. PMID: 31149544 Free PMC article.
Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001).
Tamiya M, Tamiya A, Hosoya K, Taniguchi Y, Yokoyama T, Fukuda Y, Hirano K, Matsumoto H, Kominami R, Suzuki H, Hirashima T, Uchida J, Morita M, Kanazu M, Sawa N, Kinoshita Y, Hara S, Kumagai T, Fujimoto D. Tamiya M, et al. Among authors: yokoyama t. Invest New Drugs. 2019 Dec;37(6):1266-1273. doi: 10.1007/s10637-019-00843-y. Epub 2019 Aug 7. Invest New Drugs. 2019. PMID: 31392549
Expanding the phenotype of COPA syndrome: a kindred with typical and atypical features.
Taveira-DaSilva AM, Markello TC, Kleiner DE, Jones AM, Groden C, Macnamara E, Yokoyama T, Gahl WA, Gochuico BR, Moss J. Taveira-DaSilva AM, et al. Among authors: yokoyama t. J Med Genet. 2019 Nov;56(11):778-782. doi: 10.1136/jmedgenet-2018-105560. Epub 2018 Nov 1. J Med Genet. 2019. PMID: 30385646 Free PMC article. Clinical Trial.
3,249 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback